BioSpace News Archive

Biotech Beach

BIO Returns to San Diego with Innovation and Partnering on the Menu

The annual BIO convention has returned, bringing thousands of life sciences companies worldwide to the annual networking event that could spark collaborations and deals.

June 14, 2022
·
3 min read
·
Alex Keown
Business

Pfizer-Backed Dren Nets $65M to Advance Lead Asset to Clinic

Dren Bio announced the completion a of $65M Series B financing round. New investors include Pfizer, ArrowMark Partners and Revelation Partners.

June 14, 2022
·
3 min read
·
Mark Terry
Drug Development

Alnylam Scores Another FDA Nod in hATTR

The FDA has approved Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults.

June 14, 2022
·
3 min read
·
Mark Terry
Policy

UPDATE: In Unanimous Vote, FDA Advisory Committee Recommends Moderna’s COVID Vaccine for Kids 6-17

In a unanimous vote, a panel of FDA advisors voted to recommend the approval of Moderna’s COVID-19 vaccine for children between the ages of six and 17 years old.

June 14, 2022
·
2 min read
·
Alex Keown
Drug Development

Freeline Initiates Dosing of Second Cohort in B-LIEVE Dose Confirmation Trial of FLT180a in Hemophilia B

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it has begun dosing the second cohort in its Phase 1/2 B-LIEVE dose confirmation trial of FLT180a in people with hemophilia B.

June 14, 2022
·
9 min read
Business

Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results

Sio Gene Therapies Inc. (NASDAQ: SIOX) today provided financial results for its fiscal year ended March 31, 2022.

June 14, 2022
·
6 min read
Business

Allucent Appoints Katy Moore as President of Growing Clinical Pharmacology, Modeling and Simulation Division

Global biopharmaceutical services leader, Allucent, announced today the appointment of Katy Moore, PharmD, RPh, as president of Clinical Pharmacology, Modeling and Simulation (CPMS).

June 14, 2022
·
2 min read
PROXIMIE RAISES $80 MILLION IN SERIES C FUNDING TO ACCELERATE PRODUCT EXPANSION OF FULL-SERVICE CONNECTED SURGICAL PLATFORM

Funding round led by Advent Life Sciences. New investors include Emerson Collective, SoftBank Vision Fund 2, British Patient Capital, Mubadala and the Minderoo Foundation.

June 14, 2022
·
5 min read
Lone Star Bio

Collaborative Study with Melanoma Research Foundation Confirms Patients Diagnosed with Melanoma Desire Testing with DecisionDx®-Melanoma

Study shows that DecisionDx®-Melanoma results can provide patients with knowledge and understanding regarding their prognosis and inform melanoma treatment decisions.

June 14, 2022
·
6 min read
BioMidwest

Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope

Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope.

June 14, 2022
·
3 min read